Commercial, Energy Efficiency, GHG Emissions  -  December 6, 2024

Celerion Commits to SBTi Net Zero Standards

Celerion, a global company that conducts early clinical research, announced its commitment to the Science Based Targets Initiative (SBTi), seeking to set both near term and net zero company-wide emission reduction targets in line with science-based standards.

The company pledges to align its operational strategies with the urgent call for climate action. 

“Celerion is excited to be on the forefront of this important initiative and look forward to partnering with our clients to build a better future for our global community,” said Celerion CEO Susan Thornton in a statement. “Celerion’s commitment to the SBTi is part of our broader vision for sustainable development and environmental stewardship. With our expertise and resources, we are not only focused on driving excellence in clinical research but also on contributing to global efforts in combating climate change.”

Celerion joins other pharmaceutical and biotechnology companies in taking proactive steps to lower GHG emissions. The company will collaborate with stakeholders and clients to foster innovations that align with the shared goal of more sustainability.